Ordinary Re-Weighting | Several Solactive Indices | September 2021
Solactive AKTIONR China Biotech AR Index:
In the ordinary re-weighting the following index composition will be implemented effective open 04.10.2021:
| 3SBIO INC |
| BEIGENE LTD-ADR |
| CSPC PHARMACEUTICAL GROUP LTD |
| FIBROGEN INC |
| GENSCRIPT BIOTECH CORP |
| HUTCHISON CHINA MEDITECH-ADR |
| LEES PHARMACEUTICAL HLDGS |
| LIVZON PHARMACEUTICAL GROUP INC |
| SHANGHAI FOSUN PHARMACEUTICAL GROUP CO LTD |
| SINO BIOPHARMACEUTICAL LTD ORD |
| SINOPHARM GROUP CO LTD |
| WUXI BIOLOGICS CAYMAN INC |
| YICHANG HEC CHANGJIANG PHA-H |
| ZAI LAB LTD |
Solactive ERSTE Green Invest Index:
In the ordinary re-weighting the following index composition will be implemented effective open 01.10.2021:
| ISHARES EUR HY CORP ESG EURA |
| ISHARES EURO CORP ESG UCITS |
| ISHARES MSCI EM SRI UCITS |
| ISHARES MSCI EUROPE SRI |
| ISHARES MSCI JAPAN SRI USD-A |
| ISHARES MSCI USA SRI UCITS ETF |
Solactive Europe & US Top Pharmaceuticals 2020 AR 3.5% Index:
In the ordinary re-weighting the following index composition will be implemented effective open 01.10.2021:
| ABBVIE INC |
| ASTRAZENECA PLC |
| BRISTOL-MYERS SQUIBB CO |
| JOHNSON & JOHNSON |
| MERCK & CO. INC. |
| NOVARTIS AG |
| NOVO NORDISK A/S |
| PFIZER INC |
| ROCHE HOLDING AG |
| SANOFI SA |